Skip to main content

Table 3 Follow-up studies on seropositive patients

From: Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy

Patients Antibody Testing
Number Sex Age Specificity at onset of vision loss Diagnosis of cancer No. of Samples No. of positive After treatment
P409 M 64 Recoverin Before 11 See Fig. 3 Negative after chemotherapy and radiation
P785 M 66 Recoverin 5 years after 2 2  
P536 F 72 Recoverin Before 2 2  
P718 F 64 Recoverin 6 months after 8 See Fig. 3 Reduction after Rituxan
P626 F 73 Recoverin 2 years after 5 2  
P426 F 66 Recoverin After 34 See Fig. 3 Negative after Tolpa [29]
P570 M 72 Recoverin Before 2 1  
P692 M 58 P35 9 months after 2 1 Negative after systemic steroids
P613 M 68 P35 Before 2 2  
P566 M 59 P35 Before 3 2 Negative after INFa/b
P559 F 51 Bipolar cells After 3 1 Negative after chemotherapy [13]
P561 F 55 Enolase 3 months after 5 5 Reduction after IVIG
P474 F 35 Enolase Before 3 1  
P593 F 46 Enolase 17 years after 2 2  
P660 F 65 Enolase No cancer 3 2  
P436 M 43 IPL No cancer 19 8 Negative after IVIG
P662 F 47 P35, p46 No cancer 2 2  
P580 M 54 P53, p46 No cancer 3 3 No change after oral steroids
P630 M 40 P35 No cancer 2 2  
P579 M 30 P35 No cancer 6 4 No change after oral steroids
P513 F 52 Carbonic anhydrase No cancer 2 2  
P577 M 68 P40 No cancer 2 2  
P623 F 34 Arrestin No cancer 2 2  
P653 F 28 P52 No cancer 3 3  
\